AI
LJPC

Analytic Investors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Analytic Investors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-33,633
Closed -$538K – 731
2016
Q2 		$538K Buy
+33,633
New +$603K 0.01% 467
2016
Q1 		– Sell
-9,630
Closed -$260K – 729
2015
Q4 		$260K Buy
+9,630
New +$263K ﹤0.01% 578

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Analytic Investors's LJPC Position: Q3 2016 in Review

Analytic Investors sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2016, closing a stake of 33,633 shares — an estimated $538K sold.

Analytic Investors first reported a position in LJPC in Q4 2015 and held it in 2 quarters. The position peaked at $538K in Q2 2016. 71 funds tracked by Wall St. Rank hold LJPC as of Q3 2016.

  • Analytic Investors reported no remaining La Jolla Pharmaceutical Company position as of Q3 2016 after selling out during the quarter.
  • Analytic Investors sold 33,633 La Jolla Pharmaceutical Company shares in Q3 2016, an estimated $538K.
  • Analytic Investors first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 2 quarters.
  • Analytic Investors's La Jolla Pharmaceutical Company position peaked at $538K in Q2 2016.
  • 71 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.